Term
What cells express RANK? What are they derived from?
What cells secrete RANKL? What are they derived from? |
|
Definition
- osteoclasts - macrophages
- osteoblasts - mesenchymal |
|
|
Term
Osteoprotegerin: what cell type(s) secrete it and what does it do? |
|
Definition
- mostly osteoblasts, also stromal and immune cells
- acts as a decoy receptor for RANKL, blocking it's effect on cells expressing RANK |
|
|
Term
the ratio between which proteins determines bone loss or bone increase? |
|
Definition
|
|
Term
What three things do osteoclasts secrete that effect osteoclasts?
Which stimulate their resorption activity and which inhibit it? |
|
Definition
- RANKL (stimulate) -Osteoportegrin (inhibit) - M-CSF (stimulate) |
|
|
Term
Other than bone reabsorption, what is another function of osteoclasts? |
|
Definition
- function as APC's fro T-cells |
|
|
Term
Osteoblasts are main secretors of RANKL, but other cells express this and can drive osteoclast differentiation/activation. What other cell types express RANKL? |
|
Definition
- DC's - T-cells - B-cells - monocytes - neutrophils |
|
|
Term
What cytokines stimulate cells to produce RANKL? |
|
Definition
- proinflammatory: Il-6, TNF-α, IL17 |
|
|
Term
What cytokines will inhbit osteoclast differentation/proliferation? |
|
Definition
|
|
Term
What effect will a dominant Th1 response have on osteoclasts?
Through what mechanism? |
|
Definition
- pro-osteoclast effect
- through INF-y and its activation of macrophages |
|
|
Term
What affect will a Th17 response have on osteoclast activity? |
|
Definition
|
|
Term
What is lacking in rheumatoid arthritis?
What drives this? |
|
Definition
- control of Th17
- DC release of IL23 |
|
|
Term
How do Tregs affect osteoclasts?
What cell markers are important here? |
|
Definition
- because osteoclasts are closely related to APC's, interaction with TReg's expressing CTLA-4 will inhibit interaction between their CD80/B7 and Th1 CD28. |
|
|
Term
Three mechanisms/cell types that estrogen works on? |
|
Definition
- Osteoblasts: increase activity - Osteoclasts: decrease activity - T-cell: decrease their RANKL expression |
|
|
Term
Cell types that make up white adiopse tissue? |
|
Definition
1) pre-adipocytes 2) adipocytes 3) stromal/vascular cells 4) macrophages |
|
|
Term
Adipocyte pro-inflammatory cytokines
Adipocyte anti-inflammatory cytokines |
|
Definition
Pro-inflammatory: 1) Leptin 2) Visfatin
Anti-Inflammatory: 1) Adiponectin 2) Macrophage inhibitory cytotkine (MAC1) 3) SFRP |
|
|
Term
Two adiopocyte proinflammatory cytokines and their effects |
|
Definition
1) Leptin - stimulate production of IL-6,1 and TNF-α
2) Visfatin - angiogenic |
|
|
Term
Anti-inflammatory adipocyte cytokines and their function |
|
Definition
1) Adiponectin: suppression of TNF-α, antagonist to leptin
2) Macrophage inhibitory cytokine: Stiulates adiponectin production
3) SFRP - antagonizes WAT signaling |
|
|
Term
Two macrophage derived cytokines associated with WAT? |
|
Definition
- Osteopontin: chemotactic for monocytes and macrophages
- Resistin: antagonist of adiponectin and promotes TNF-α and IL-6 production |
|
|
Term
Two major types of macrophages associated with WAT? |
|
Definition
M1 - proinflammatory
M2 - anti-inflammatory |
|
|
Term
What is the dominant macrophage type in healthy adipose tissue?
What type of environment is this?
What adipocytokines are associated with it? |
|
Definition
- M2
- anti-inflammatory environment
- Adiponectin, MAC-1, SFRP |
|
|
Term
What cytokines do M2's in a non-obese person upregulate?
What do they downregulate? |
|
Definition
-Upregulate: IL4, IL10
- downregulate: NFκB |
|
|
Term
What does "Stuffing" of adiopoctyes cause? |
|
Definition
- activation of signal pathway that results in pro-inflammatory milieu leading to insulin resistance |
|
|
Term
most potent monocyte attractant from adipocytes and its receptor? |
|
Definition
|
|
Term
Role of osteopontin in obesity? |
|
Definition
- draws monocytes out of blood vessels and into the adipose tissue. |
|
|
Term
Obesity and cholesterol/arterial plaque |
|
Definition
- choelesterol crystals in arterial plaque may draw macrophages to the area perpetuating inflammation |
|
|